Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Minim Invasive Gynecol ; 25(1): 99-104, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28807807

RESUMO

STUDY OBJECTIVE: To evaluate the impact of endometriosis staging and endometriomas on in vitro fertilization (IVF) outcome and to assess the optimal time interval between laparoscopy and IVF. DESIGN: A retrospective clinical study (Canadian Task Force classification II1). SETTING: A university-affiliated private infertility clinic. PATIENTS: Two hundred sixteen infertile patients with endometriosis and 209 infertile patients without endometriosis. INTERVENTIONS: Laparoscopy, IVF. MEASUREMENTS AND MAIN RESULTS: Patients with endometriosis were classified according to American Society for Reproductive Medicine criteria; 58, 67, 63, and 28 patients had stages 1 through 4 disease, respectively. Patients with endometriosis had significantly lower estradiol on trigger day (9986 ± 6710 vs 12 220 ± 9414 pg/mL, respectively) and number of retrieved oocytes (12.7 ± 8.6 vs 14.0 ± 10, respectively) compared with controls. We found a consistent decline in clinical and ongoing pregnancy rates with increasing stage of endometriosis. The presence of endometrioma in patients with stages 3 and 4 endometriosis did not alter IVF outcome. Patients with a time interval of 7 to 12 and 13 to 25 months after surgery had a favorable outcome. CONCLUSION: IVF pregnancy rate was negatively correlated with endometriosis severity. The presence of endometriomas had no impact on IVF clinical outcome. The optimal time to perform IVF appears to be between 7 and 25 months after endometriosis surgery.


Assuntos
Endometriose/cirurgia , Fertilização in vitro/estatística & dados numéricos , Infertilidade Feminina/cirurgia , Taxa de Gravidez , Doenças Uterinas/cirurgia , Adulto , Estudos de Casos e Controles , Endometriose/complicações , Endometriose/epidemiologia , Feminino , Humanos , Infertilidade Feminina/epidemiologia , Infertilidade Feminina/etiologia , Laparoscopia/métodos , Laparoscopia/estatística & dados numéricos , Recuperação de Oócitos/métodos , Recuperação de Oócitos/estatística & dados numéricos , Gravidez , Resultado da Gravidez/epidemiologia , Estudos Retrospectivos , Fatores de Tempo , Tempo para Engravidar , Doenças Uterinas/complicações , Doenças Uterinas/epidemiologia
2.
Reprod Biomed Online ; 35(5): 602-608, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28826601

RESUMO

Anti-Müllerian hormone (AMH) is a standard marker of ovarian reserve. Correlation between AMH and egg euploidy is controversial. We evaluated the association between AMH and blastocyst euploidy rate examined by pre-implantation genetic screening (PGS). This retrospective study was conducted at the CReATe Fertility Centre. We included single IVF cycles of 216 infertile couples, which resulted in 911 blastocysts subjected to array comparative genomic hybridization and evaluated IVF outcome after embryo transfer. The average age and median AMH of female patients were 37.2 (SD = 3.8) and 20 pmol/l, respectively, and the average euploidy rate was 38.3%. Using multivariate regression controlling for age, antral follicle count, body mass index and parity, there was a significant association between serum AMH and proportion of euploid embryos (P = 0.02), due to the dominant ≤36 age group in which significant correlation between AMH and euploidy rate (P = 0.02) was demonstrated. Clinical outcome was similar, including biochemical, clinical and ongoing pregnancy rates as well as pregnancy loss. This study shows a correlation between AMH and aneuploidy rate, specifically among infertile patients younger than 37 years old. Study limitations are discussed.


Assuntos
Aneuploidia , Hormônio Antimülleriano/sangue , Infertilidade/diagnóstico , Ploidias , Transferência Embrionária , Feminino , Fertilização in vitro , Humanos , Infertilidade/etiologia , Masculino , Indução da Ovulação , Gravidez , Taxa de Gravidez , Diagnóstico Pré-Implantação , Estudos Retrospectivos
3.
Minerva Ginecol ; 69(1): 23-28, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28116885

RESUMO

BACKGROUND: Missed abortion (MA) can be managed expectantly, medically or surgically. Surgical management has been performed safely in the office setting by suction dilation and curettage (D&C). Prior studies suggest that intraoperative ultrasound guidance (USG) may reduce complications for first-trimester therapeutic abortion. The aim of this study was to evaluate the safety of office D&C for MA using real-time USG. METHODS: This retrospective cohort study included 255 patients who underwent office D&C under USG for first trimester MA at a single university-affiliated fertility clinic during January 2011-December 2013. Transabdominal USG was utilized during the procedure and was immediately followed by a transvaginal ultrasound examination to confirm full evacuation. Intra- and postoperative complication rates were compared to previously published data. RESULTS: There were no intraoperative complications, including excessive blood loss or uterine perforation. Two of the 255 patients (0.87%) were diagnosed with RPOCs requiring uterine re-evacuation. This rate of RPOCs was superior to rates previously reported for D&Cs without USG (2.6-4.9%, P=0.046). There were no other post procedure complications identified. CONCLUSIONS: We observed very low complications rate in Office-based D&C under USG, lower than those reported in the literature with unguided D&C.


Assuntos
Aborto Retido/cirurgia , Dilatação e Curetagem/métodos , Complicações Pós-Operatórias/epidemiologia , Ultrassonografia de Intervenção/métodos , Adulto , Estudos de Coortes , Dilatação e Curetagem/efeitos adversos , Feminino , Humanos , Complicações Intraoperatórias/epidemiologia , Pessoa de Meia-Idade , Visita a Consultório Médico , Gravidez , Estudos Retrospectivos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...